Loss of function variants in SLC6A1 have been associated with a spectrum of neurodevelopmental disorders, including autism spectrum disorders (ASD), developmental delay and intellectual disability (ID), and a variety of seizure types including absence seizures and myoclonic-atonic seizures [1–6]. The gene discussed is SLC6A1; the disease is autism spectrum disorder.